伴有不对称性肌无力的中性脂质贮积病伴肌病：一例报告
Neutral lipid storage disease with myopathy presenting asymmetrical muscle weakness: a case report.
作者信息
Zhang Jinru, Han Jingzhe, Wang Yaye, Wu Yue, Song Xueqin, Ji Guang
机构信息
Department of Neurology, The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China.
Department of Neurology, Harrison International Peace Hospital Hengshui, Hebei, China.
出版信息
Int J Clin Exp Pathol. 2020 Mar 1;13(3):559-562. eCollection 2020.
Abstract
NLSDM is a rare metabolic myopathy caused by mutations in the patatin-like phosphatase domain protein 2 (PAPLA2) genes. In the present study, we describe the clinical and genetic findings in our Chinese patient with NLSDM. Sequence analysis of PNPLA2 gene was performed. Gene analysis for PNPLA2 revealed an identical homozygous mutation c.757+1G>T in our patient. The clinical symptoms of our patient are related to the type of mutation in the PNPLA2 gene and environmental effects.
摘要
中性脂质贮积病伴鱼鳞病样红皮病（NLSDM）是一种由帕他汀样磷脂酶结构域蛋白2（PAPLA2）基因突变引起的罕见代谢性肌病。在本研究中，我们描述了中国NLSDM患者的临床和基因学发现。对PNPLA2基因进行了序列分析。PNPLA2基因分析显示，我们的患者存在相同的纯合突变c.757+1G>T。我们患者的临床症状与PNPLA2基因的突变类型及环境影响有关。
相似文献
1
Neutral lipid storage disease with myopathy presenting asymmetrical muscle weakness: a case report.伴有不对称性肌无力的中性脂质贮积病伴肌病：一例报告
Int J Clin Exp Pathol. 2020 Mar 1;13(3):559-562. eCollection 2020.
2
Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.中国西南部患有伴有肌病的中性脂质贮积病（NLSDM）的患者。
Clin Neurol Neurosurg. 2018 May;168:102-107. doi: 10.1016/j.clineuro.2018.03.001. Epub 2018 Mar 5.
3
Neutral lipid storage disease with myopathy in China: a large multicentric cohort study.中国中性脂肪贮积病伴肌病：一项大型多中心队列研究。
Orphanet J Rare Dis. 2019 Oct 26;14(1):234. doi: 10.1186/s13023-019-1209-z.
4
A novel mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy.一种新型突变导致两名早发型但进展缓慢的严重肌病的NLSDM患者的RNA和蛋白质表达完全丧失。
Genes Dis. 2019 Jul 29;8(1):73-78. doi: 10.1016/j.gendis.2019.07.006. eCollection 2021 Jan.
5
Dilated cardiomyopathy caused by mutation of the gene: a case report and literature review.基因突引发的扩张型心肌病：一例报告及文献综述
Front Genet. 2024 Jul 25;15:1415156. doi: 10.3389/fgene.2024.1415156. eCollection 2024.
6
A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.PNPLA2 中的一种新突变导致伴有肌病和甘油三酯沉积性心肌病血管病的中性脂质贮积病：一例病例报告及文献复习。
Neuromuscul Disord. 2014 Jul;24(7):634-41. doi: 10.1016/j.nmd.2014.04.001. Epub 2014 Apr 21.
7
Two PNPLA2 heterozygous mutations result in neutral lipid storage disease with myopathy: a case report.两种载脂蛋白 L 家族成员 2 杂合突变导致伴有肌病的中性脂肪贮积症：病例报告。
BMC Musculoskelet Disord. 2024 Aug 23;25(1):661. doi: 10.1186/s12891-024-07772-9.
8
Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.由于新型PNPLA2突变导致脂肪酶活性完全丧失，引发迟发性中性脂质贮积病，该患者患有肌病并伴有轻微心脏受累。
Neuromuscul Disord. 2017 May;27(5):481-486. doi: 10.1016/j.nmd.2017.01.011. Epub 2017 Jan 17.
9
Case Report: PNPLA2 Gene Complex Heterozygous Mutation Leading to Neutral Lipid Storage Disease With Myopathy.病例报告：PNPLA2基因复合杂合突变导致伴有肌病的中性脂质贮积病
Front Integr Neurosci. 2021 Jan 22;14:554724. doi: 10.3389/fnint.2020.554724. eCollection 2020.
10
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM.诱导多能干细胞的产生作为NLSDM的疾病模型。
Mol Genet Metab. 2017 May;121(1):28-34. doi: 10.1016/j.ymgme.2017.03.009. Epub 2017 Apr 3.
引用本文的文献
1
Deregulation of Lipid Homeostasis: A Fa(c)t in the Development of Metabolic Diseases.脂质稳态失调：代谢性疾病发生的一个因素。
Cells. 2020 Dec 4;9(12):2605. doi: 10.3390/cells9122605.
本文引用的文献
1
Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant.中性脂肪贮积病伴肌病：一种罕见的 PNPLA2 变异体的进一步表型特征描述。
Neuromuscul Disord. 2018 Jul;28(7):606-609. doi: 10.1016/j.nmd.2018.04.010. Epub 2018 Apr 19.
2
Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China.中国西南部患有伴有肌病的中性脂质贮积病（NLSDM）的患者。
Clin Neurol Neurosurg. 2018 May;168:102-107. doi: 10.1016/j.clineuro.2018.03.001. Epub 2018 Mar 5.
3
Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.由于新型PNPLA2突变导致脂肪酶活性完全丧失，引发迟发性中性脂质贮积病，该患者患有肌病并伴有轻微心脏受累。
Neuromuscul Disord. 2017 May;27(5):481-486. doi: 10.1016/j.nmd.2017.01.011. Epub 2017 Jan 17.
4
A novel mutation in PNPLA2 causes neutral lipid storage disease with myopathy and triglyceride deposit cardiomyovasculopathy: a case report and literature review.PNPLA2 中的一种新突变导致伴有肌病和甘油三酯沉积性心肌病血管病的中性脂质贮积病：一例病例报告及文献复习。
Neuromuscul Disord. 2014 Jul;24(7):634-41. doi: 10.1016/j.nmd.2014.04.001. Epub 2014 Apr 21.
5
PNPLA2 mutation: a paediatric case with early onset but indolent course.PNPLA2 基因突变：一例早发型但进展缓慢的儿科病例。
Neuromuscul Disord. 2013 Dec;23(12):986-91. doi: 10.1016/j.nmd.2013.08.008. Epub 2013 Aug 30.
6
Neutral lipid storage disease with myopathy: a whole-body nuclear MRI and metabolic study.中性脂肪贮积病伴肌病：全身核 MRI 和代谢研究。
Mol Genet Metab. 2013 Feb;108(2):125-31. doi: 10.1016/j.ymgme.2012.12.004. Epub 2012 Dec 28.
7
Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function.新型 ATGL 错义突变对 NLSD-M 临床表型的贡献：极低的脂肪酶活性可能有助于保护心脏功能。
Hum Mol Genet. 2012 Dec 15;21(24):5318-28. doi: 10.1093/hmg/dds388. Epub 2012 Sep 17.
8
A novel mutation in PNPLA2 leading to neutral lipid storage disease with myopathy.PNPLA2基因中的一种新型突变导致伴有肌病的中性脂质贮积病。
Arch Neurol. 2012 Sep;69(9):1190-2. doi: 10.1001/archneurol.2011.2600.
9
Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy.中国汉族中性脂肪贮积病伴肌病患者中新型 PNPLA2 基因突变。
J Hum Genet. 2012 Oct;57(10):679-81. doi: 10.1038/jhg.2012.84. Epub 2012 Jul 26.
10
Differential control of ATGL-mediated lipid droplet degradation by CGI-58 and G0S2.CGI-58 和 G0S2 对 ATGL 介导的脂滴降解的差异调控。
Cell Cycle. 2010 Jul 15;9(14):2719-25. doi: 10.4161/cc.9.14.12181. Epub 2010 Jul 27.
Zotero 插件